• Profile
Close

Low-dose aspirin administered for venous thromboembolism prophylaxis reduces the incidence of heterotopic ossification in total joint arthroplasty

Journal of Arthroplasty Dec 23, 2020

Van Nest DS, Clarkson S, Chisari E, et al. - This study was undertaken to investigate whether aspirin, when applied as venous thromboembolism prophylaxis, influenced the rate of heterotopic ossification (HO) formation following total joint arthroplasty (TJA). Between January 2016 and June 2018, researchers analyzed a longitudinally maintained database to distinguish all patients who had undergone primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) for osteoarthritis with at least 3-month radiographic follow-up. For analysis, 1,238 THAs and 1,051 TKAs were included. They reviewed radiographs and HO formation graded according to the Brooker classification. They obtained patient demographic and venous thromboembolism (VTE) prophylaxis data and reviewed them for accuracy. The effect of ASA on HO formation was assessed by performing univariate and multivariate analysis. For VTE prophylaxis, individuals undergoing primary TJA receiving aspirin were less likely to develop HO in comparison with individuals who were administered non-aspirin VTE prophylaxis.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay